• Access To Medicines

Influencing and shaping our sector, BIA update: October 2018 - January 2019

The BioIndustry Association (BIA)’s ongoing engagement enables our members’ voices to be heard at the highest levels. This quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences industry, from October 2018 to January 2019.

Results of BIA survey UK R&D incentives for orphan medicines in no-deal Brexit November 2018

Influencing and shaping our sector, BIA update: July - October 2018

This quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences industry, from July to October 2018.

BIA response to the Department of Health and Social Care's consultation on proposed changes to the statutory scheme to control costs of branded health service medicines

The BIA has responded to the Department of Health and Social Care's consultation on proposed changes to the statutory scheme to control costs of branded health service medicines.